Request Demo
Recent blog posts
Latest Hotspot
8 min read
Distal hereditary motor neuropathy Indication Strategy Report 2026: HSPB1, Trials and Deals
30 July 2026
2026 Distal hereditary motor neuropathy indication strategy covering epidemiology, HSPB1 biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Hereditary motor neuropathy type 2 Indication Strategy Report 2026: HSPB8, Trials and Deals
30 July 2026
2026 Hereditary motor neuropathy type 2 indication strategy covering epidemiology, HSPB8 biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Hereditary spastic paraplegia type 4 Indication Strategy Report 2026: SPAST, Trials and Deals
30 July 2026
2026 Hereditary spastic paraplegia type 4 indication strategy covering epidemiology, SPAST biology, active trials, transactions, unmet need, competition and…
Latest Hotspot
8 min read
Hereditary spastic paraplegia type 15 Indication Strategy Report 2026: ZFYVE26, Trials and Deals
30 July 2026
2026 Hereditary spastic paraplegia type 15 indication strategy covering epidemiology, ZFYVE26 biology, active trials, transactions, unmet need, competition and…
Latest Hotspot
8 min read
Hereditary spastic paraplegia type 50 Indication Strategy Report 2026: AP4M1, Trials and Deals
30 July 2026
2026 Hereditary spastic paraplegia type 50 indication strategy covering epidemiology, AP4M1 biology, active trials, transactions, unmet need, competition and…
Latest Hotspot
8 min read
Hereditary spastic paraplegia type 11 Indication Strategy Report 2026: SPG11, Trials and Deals
30 July 2026
2026 Hereditary spastic paraplegia type 11 indication strategy covering epidemiology, SPG11 biology, active trials, transactions, unmet need, competition and…
Latest Hotspot
8 min read
Hereditary spastic paraplegia type 7 Indication Strategy Report 2026: SPG7, Trials and Deals
30 July 2026
2026 Hereditary spastic paraplegia type 7 indication strategy covering epidemiology, SPG7 biology, active trials, transactions, unmet need, competition and…
Latest Hotspot
8 min read
Fast-channel congenital myasthenic syndrome Indication Strategy Report 2026: CHRNE, Trials and Deals
30 July 2026
2026 Fast-channel congenital myasthenic syndrome indication strategy covering epidemiology, CHRNE biology, active trials, transactions, unmet need, competition…
Latest Hotspot
8 min read
Congenital myasthenic syndrome Indication Strategy Report 2026: CHRNE, Trials and Deals
30 July 2026
2026 Congenital myasthenic syndrome indication strategy covering epidemiology, CHRNE biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Morvan syndrome Indication Strategy Report 2026: CASPR2, Trials and Deals
30 July 2026
2026 Morvan syndrome indication strategy covering epidemiology, CASPR2 biology, active trials, transactions, unmet need, competition and market attractiveness.
Latest Hotspot
8 min read
MUSK myasthenia gravis Indication Strategy Report 2026: MUSK, Trials and Deals
30 July 2026
2026 MUSK myasthenia gravis indication strategy covering epidemiology, MUSK biology, active trials, transactions, unmet need, competition and market attractiveness.
Latest Hotspot
8 min read
Isaacs syndrome Indication Strategy Report 2026: VGKC, Trials and Deals
30 July 2026
2026 Isaacs syndrome indication strategy covering epidemiology, VGKC biology, active trials, transactions, unmet need, competition and market attractiveness.